首页/数据集/Hostility Events in Adult and Paediatric Placebo-Controlled Trials on Therapy and in Withdrawal Phase

Hostility Events in Adult and Paediatric Placebo-Controlled Trials on Therapy and in Withdrawal Phase

Figshare2015-12-02 更新2026-05-11 收录

数据链接：

https://figshare.com/articles/dataset/_Hostility_Events_in_Adult_and_Paediatric_Placebo_Controlled_Trials_on_Therapy_and_in_Withdrawal_Phase_/1078333 数据链接链接失效反馈

官方服务：

资源简介：

Hostility Events in Adult and Paediatric Placebo-Controlled Trials on Therapy and in Withdrawal Phase

应用场景：

创建时间：

2015-12-02

药物临床试验

疫情数据透明度

August 19, 2014. 6:00AM (Bogotá time zone) Third request of retraction: NEJM, Boehringer, Pradaxa, dabigatran, RE-LY study. (1st URL attached below). <strong

DataCite Commons2020-09-04 更新80

Supplementary Material for: A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling

病理性赌博治疗

药物临床试验

Background/Aims: Effective treatment strategies are needed for the treatment of pathological gambling (PG). The efficacy of as-needed naltrexone was assessed in a single-centre, randomised, double-bli

NIAID Data Ecosystem30

Dataset from A Two-part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a High, Single Oral Dose of GSK1278863 (Part A), and a Randomized, Single-blind, Placebo- and Positive-controlled, Four-way Crossover Study to Assess the Effect of Single, Oral Dose of GSK1278863 on Cardiac Repolarization (Part B) in Healthy Volunteers

药物临床试验

心脏复极化评估

This study is being performed to comply with regulatory requirements that all new non-antiarrhythmic drugs must be assessed for potential effects on cardiac repolarization through electrocardiographic

NIAID Data Ecosystem00

Supplementary Table S1 from ERBB3-Independent Activation of the PI3K Pathway in EGFR-Mutant Lung Adenocarcinomas

EGFR突变肺癌靶向治疗

药物临床试验

Supplementary Table S1. List of mice treated with erlotinib.

Figshare2015-03-15 更新70

A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Subjects, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.

HIV抗病毒治疗

药物临床试验

The purpose of this study is to determine the antiviral activity, safety and tolerability of TMC114, formulated as an oral tablet, and administered with a low dose of ritonavir

DataCite Commons2024-12-02 更新10

Hostility Events in Adult and Paediatric Placebo-Controlled Trials on Therapy and in Withdrawal Phase

资源简介：

相关数据集